Concepedia

Mei Wu

MW

31

Publications

2.8K

Citations

21

H-Index

2000

Active since

Affiliations

Sichuan University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

West China Second University Hospital of Sichuan University

West China Medical Center of Sichuan University

West China Hospital of Sichuan University

Mei Wu is an author at Sichuan University specializing in medicine, immunology, and obstetrics.

ORCID

Top concepts

Publications per year

2000–2024

31

Publications

31

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone

B Charbonnel, Avraham Karasik, Ji Liu et al. · Diabetes Care · 2006 · 786 citations · Full text

Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women<sup>1</sup>

Richard P. Tonino, Pierre J. Meunier, Ronald Emkey et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 337 citations

, , +17

Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes

Russell Scott, Mei Wu, Miguel A. Sánchez et al. · International Journal of Clinical Practice · 2006 · 259 citations

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

Itamar Raz, Yu Chen, Mei Wu et al. · Current Medical Research and Opinion · 2008 · 259 citations

Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes

M Hanefeld, Gary Herman, Mei Wu et al. · Current Medical Research and Opinion · 2007 · 159 citations

Rows per page

1–5 of 31